ASTX295
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ASTX295, covering 2025-04-09 to 2025-04-09. Get the full timeline:
Most recent: Clinical Trial Update: Study of ASTX295 in Patients With Solid Tumors With Wild-Type p53 [Phase 1]